Statistics from Altmetric.com
To the editor: The guidance on drug-eluting stents by Richarson et al1is a typical application of the value-based approach that NICE systematically uses to examine costs and benefits of innovative treatments.
In countries like Italy, where national regulatory agencies do not use any value-based approach in their approval process, appraisals on whether or not innovative interventions are value for money are left to individual researchers …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.